AstraZeneca appoints Iskra Reic as EVP to lead international markets
December 2024- AstraZeneca announced the appointment of Iskra Reic as Executive Vice…
Beyfortus Approved in China: Could This Be the Answer to Preventing RSV in Infants?
China- January 2024- China has approved Beyfortus (nirsevimab), a newly developed long-acting…